The world's population has become heavier in the last 35 years. More than 1.9 billion adults were overweight in 2014, and a third of these were obese, according to the World Health Organization (WHO). WHO predicts that the number of overweight and obese children under the age of five will rise from about 42 million in 2013 to 70 million by 2025.  

In a 2014 study, McKinsey Global Institute assessed the current impact to society of 14 major problems caused by humans (see chart). According to this assessment, obesity is one of the top three global social burdens caused by human beings. McKinsey’s findings suggest that every year, obesity costs the world $2 trillion and is a cause of 5% of deaths. McKinsey’s estimate of the economic toll of obesity includes the cost of lost economic productivity through the loss of productive life years, direct costs to health-care systems and the investment costs needed to mitigate the impact of obesity.

The food industry is adding more and more sugar to food, which consumers are largely unaware of, as it is mostly hidden.  Products as diverse  as flavoured water, sausages, mayonnaise, and even bread all contain sugar to make them more palatable and increase shelf life. Sugar  has no nutritional value, gives no feeling of fullness and is acknowledged to be a major factor in causing obesity and diabetes.  Robert Lustig, an American paediatric endocrinologist at the University of California, also called “Dr. Sugar”, argues that fructose (too much) and fibre (not enough) appear to be cornerstones of the obesity epidemic.  He also points out that 20% of obese people actually have perfectly normal metabolic functioning, while instead 40% of normal-weight people are at risk as they suffer from metabolic dysfunctioning without knowing it.

How do we play this theme?

Obesity can be prevented, but it is a global phenomenon that will not easily disappear. Governments around the world are actively fighting to reduce the direct and indirect costs of obesity, using weapons that range from taxes on unhealthy products to subsidies for programs in areas such as medicine development.

Raising awareness of healthy eating patterns is also a key tool in government programs. Many public health organizations are pushing for more stringent measures in food labelling and marketing to children and for a stronger food reformulation program that targets unhealthy ingredients like sugar, fat and salt. In the private sector, an increasing number of corporates are proactively promoting healthy living.

Vida sana, inversión próspera

The battle against obesity and the growing public awareness of the benefits of healthier lifestyles create multiple opportunities for investors. These opportunities may be found, for example, in the areas of healthcare, biotech and consumer-related industries such as food, general health and fitness.

The worldwide medical device industry is investing heavily in research and development related to diabetes and obesity. Direct investment is going into creating an artificial pancreas, which will help patients move away from insulin injections, as well as into gastric bands, which help patients eat less. Indirect investment is going into medical devices that target cardiovascular disease, which may be a function of obesity.

In the food and beverage industry, growth expectations for natural and organic food and drinks are quite high, given these products’ favourable perception and the high retail margins they deliver. In other consumer markets, stocks with exposure to themes such as fitness, physical activity and sportswear will be well-placed to benefit from the growing number of people engaging in sports.

In addition to assessing the most promising and most responsible investment opportunities offered by current trends, NN Investment Partners also actively engages with companies across different sectors to direct them to areas such as healthy living. 


The elements contained in this document have been prepared solely for the purpose of information and do not constitute an offer, in particular a prospectus or any invitation to treat, buy or sell any security or to participate in any trading strategy. This document is intended for press use only. While particular attention has been paid to the contents of this document, no guarantee, warranty or representation, express or implied, is given to the accuracy, correctness or completeness thereof. Any information given in this document may be subject to change or update without notice. Neither NN Investment Partners B.V., NN Investment Partners Holdings N.V. nor any other company or unit belonging to the NN Group, nor any of its officers, directors or employees can be held directly or indirectly liable or responsible with respect to the information and/or recommendations of any kind expressed herein. The information contained in this document cannot be understood as provision of investment services. If you wish to obtain investment services please contact our office for advice. Use of the information contained in this document is solely at your risk. Investment sustains risk. Please note that the value of your investment may rise or fall and also that past performance is not indicative of future results and shall in no event be deemed as such. This document is not intended and may not be used to solicit sales of investments or subscription of securities in countries where this is prohibited by the relevant authorities or legislation. Any claims arising out of or in connection with the terms and conditions of this disclaimer are governed by Dutch law.